NASDAQ: CALC - CalciMedica, Inc.

Yield per half year: +1.39%
Sector: Healthcare

Share chart CalciMedica, Inc.

Extended chart Simple chart
Financial Markets by TradingView

About

CalciMedica, Inc., a clinical-stage biotechnology company, focuses on developing therapies for life-threatening inflammatory diseases with unmet needs. Its proprietary technology targets the inhibition of calcium release-activated (CRAC) channels designs to modulate the immune response and protect against tissue cell injury in life-threatening inflammatory diseases. Its lead product candidate is Auxora, a proprietary intravenous-formulated CRAC channel inhibitor for the treatment of acute pancreatitis, asparaginase-associated acute pancreatitis, and acute kidney injury.

More details
The company is based in La Jolla, California.
Add to compare list
Add to watchlist
Add to portfolio
Add to notification price

EBITDA -0.0372
Число акций ао 0.00568 млрд
P/BV 2.03
Цена ао 4.19
ISIN US38942Q2021
Сайт https://www.calcimedica.com
EV/EBITDA 0.4266
Валюта usd
IPO date 2020-09-25
Sector Health Care
Industry Biotechnology
Валюта отчета usd
Change price per day: +2.58% (4.27)
Change price per week: -3.1% (4.52)
Change price per month: -12.92% (5.03)
Change price per 3 month: +3.3% (4.24)
Change price per half year: +1.39% (4.32)
Change price per year: +82.5% (2.4)
Change price per 3 year: +17.43% (3.73)
Change price per year to date: +24.96% (3.505)
All parameters

Underestimation

Title Value Grade
P/S 0 0
P/BV 1.65 8
P/E 0 0
EV/EBITDA -0.3639 0
Total: 3.5

Efficiency

Title Value Grade
ROA, % -281.96 0
ROE, % -421.2 0
Total: 0

Dividends

Title Value Grade
Div yield, % 0 0
DSI 0 0
Total: 0

Debt

Title Value Grade
Debt/EBITDA 0 10
Total: 10

Growth impulse

Title Value Grade
Yield Revenue, % 0 0
Yield Ebitda, % -41.35 0
Yield EPS, % -71.73 0
Total: 0
More

Institutions Volume Share, %
Orbimed Advisors LLC. 297380 5.25
Bml Capital Management, LLC 145424 2.57
Meritage Portfolio Management 46000 0.81
Geode Capital Management, LLC 13354 0.24
First Manhattan Company 13226 0.23
Tower Research Capital LLC (TRC) 1417 0.03
Morgan Stanley 856 0.02
Bank of America Corporation 507 0.01
Wells Fargo & Company 16 0
Cutler Group LP 14 0

ETF Share, % Profitability for 1 year, % Dividends, %
iShares Micro-Cap ETF 0.00805 43.316995205115 1.54048



Head Job title Payment Year of birth
Dr. A. Rachel Leheny Ph.D. CEO & Director 852.84k 1963 (61 year)
Mr. Eric W. Roberts Chief Business Officer & Vice Chairman of the Board 757.4k 1964 (60 years)
Dr. Anjana Rao Ph.D. Co-Founder and Scientific Advisor N/A
Dr. Patrick Hogan Ph.D. Co-Founder and Scientific Advisor N/A
Dr. Stefan Feske M.D. Co-Founder and Scientific Advisor N/A
Dr. Kenneth A. Stauderman Ph.D. Co-Founder & Chief Scientific Officer 615.59k 1953 (71 year)
Mr. Daniel E. Geffken M.B.A. Interim Chief Financial Officer N/A 1957 (67 years)
Mr. John M. Dunn J.D. General Counsel N/A 1952 (72 years)
Mr. Michael J. Dunn M.B.A., MBA President & COO N/A 1956 (68 years)
Dr. Sudarshan Hebbar M.D. Chief Medical Officer 1965 (59 years)

Address: United States, La Jolla. CA, 505 Coast Boulevard South - open in Google maps, open in Yandex maps
Website: https://www.calcimedica.com